| abstract |
This invention provides for prodrug Compounds I, pharmaceutical compositions thereof, and their use in treating HIV infection: n n n n n n n n n n n n wherein: n X is C or N with the proviso that when X is N, R 1 does not exist; n W is C or N with the proviso that when W is N, R 2 does not exist; n V is C; n E is hydrogen or a pharmaceutically acceptable salt thereof; and n Y is selected from the group consisting of n n n n n n n n n n n n n n n n wherein: n L and M are independently selected from the group consisting of C 1 -C 6 alkyl, phenyl, benzyl, trialkylsilyl, -2,2,2-trichloroethoxy and 2-trimethylsilylethoxy. |